|
PSMG1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.71649999999702E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.22760000001543E-07 |
| Normal-vs-Stage2 |
1.458530E-03 |
| Normal-vs-Stage3 |
1.065190E-01 |
| Normal-vs-Stage4 |
7.114400E-01 |
| Stage1-vs-Stage2 |
7.478800E-01 |
| Stage1-vs-Stage3 |
4.583400E-01 |
| Stage1-vs-Stage4 |
1.577220E-01 |
| Stage2-vs-Stage3 |
4.064000E-01 |
| Stage2-vs-Stage4 |
1.503630E-01 |
| Stage3-vs-Stage4 |
4.674400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.026350E-04 |
| Normal-vs-AfricanAmerican |
1.816590E-01 |
| Normal-vs-Asian |
1.282280E-03 |
| Caucasian-vs-AfricanAmerican |
5.944200E-01 |
| Caucasian-vs-Asian |
2.856400E-01 |
| AfricanAmerican-vs-Asian |
4.065800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.77056999999259E-05 |
| Normal-vs-Female |
7.499800E-02 |
| Male-vs-Female |
1.280830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.233800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.166240E-02 |
| Normal-vs-Age(61-80Yrs) |
5.46999999961884E-07 |
| Normal-vs-Age(81-100Yrs) |
6.073800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.000400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.755800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.740600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.732600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.063160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.978200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.963800E-02 |
| Normal-vs-Grade 2 |
1.90597999999431E-05 |
| Normal-vs-Grade 3 |
2.603900E-02 |
| Normal-vs-Grade 4 |
1.755590E-01 |
| Grade 1-vs-Grade 2 |
9.627400E-01 |
| Grade 1-vs-Grade 3 |
7.341000E-01 |
| Grade 1-vs-Grade 4 |
4.954600E-01 |
| Grade 2-vs-Grade 3 |
6.427400E-01 |
| Grade 2-vs-Grade 4 |
3.480200E-01 |
| Grade 3-vs-Grade 4 |
6.512600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.92600000004095E-06 |
| Normal-vs-ccB subtype |
7.102700E-03 |
| ccA subtype-vs-ccB subtype |
9.636600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.317300E-03 |
| Normal-vs-N1 |
8.25060000000377E-05 |
| N0-vs-N1 |
1.865750E-01 |
|
|
